In summary, our study proposed the synergistic inhibition effect of PLK1 inhibitor with TMZ on glioblastoma stem‐like cells and suggested the critical role of PLK1 in glioma stem cells progression, providing new treatment strategies for gliomas. This evidence concerns the gene PLK1 and central nervous system cancer.